Are nondepolarizing neuromuscular blocking agents truly a risk factor for late-onset ventilator-associated pneumonia?

Intensive Care Med. 2005 Aug;31(8):1137; author reply 1138. doi: 10.1007/s00134-005-2672-7. Epub 2005 Jun 2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amphotericin B / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Gentamicins / therapeutic use
  • Humans
  • Neuromuscular Nondepolarizing Agents / adverse effects
  • Neuromuscular Nondepolarizing Agents / therapeutic use
  • Pneumonia / etiology*
  • Respiration, Artificial / adverse effects*
  • Risk Factors
  • Wounds and Injuries / therapy

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Neuromuscular Nondepolarizing Agents
  • Amphotericin B